Basilea Pharmaceutica
BSLN.SW
#5986
Rank
S$1.38 B
Marketcap
S$111.78
Share price
0.14%
Change (1 day)
44.33%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: S$5.36

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is S$5.36. In 2025 the company made an earnings per share (EPS) of S$5.36 a decrease over its 2024 EPS that were of S$9.17.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025S$5.36-41.53%
2024S$9.17586.89%
2023S$1.33-6.28%
2022S$1.42-273.94%
2021S-$0.82-60.87%
2020S-$2.09-24.46%
2019S-$2.77-26.92%
2018S-$3.7959.83%
2017S-$2.37-63.06%
2016S-$6.42-19.26%
2015S-$7.9546.12%
2014S-$5.4410.07%
2013S-$4.94-36.76%
2012S-$7.82-5.42%
2011S-$8.26-153.36%
2010S$15.49-198.47%
2009S-$15.73-15.34%
2008S-$18.5816.7%
2007S-$15.9236.07%
2006S-$11.7079.07%
2005S-$6.53-46.79%
2004S-$12.289.83%
2003S-$11.18-38.94%
2002S-$18.31